icad inc
iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company's ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurat… Read more
Market Cap & Net Worth: icad inc (ICAD)
icad inc (NASDAQ:ICAD) has a market capitalization of $106.31 Million ($106.31 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18260 globally and #6823 in its home market, demonstrating a 4.03% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying icad inc's stock price $3.87 by its total outstanding shares 27470900 (27.47 Million).
icad inc Market Cap History: 2015 to 2025
icad inc's market capitalization history from 2015 to 2025. Data shows change from $142.02 Million to $106.31 Million (-0.41% CAGR).
Index Memberships
icad inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #501 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1692 of 3165 |
Weight: icad inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
icad inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how icad inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.56x
icad inc's market cap is 2.56 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $142.02 Million | $41.55 Million | -$32.45 Million | 3.42x | N/A |
| 2016 | $88.87 Million | $26.34 Million | -$10.10 Million | 3.37x | N/A |
| 2017 | $94.50 Million | $28.10 Million | -$14.26 Million | 3.36x | N/A |
| 2018 | $101.64 Million | $25.62 Million | -$9.02 Million | 3.97x | N/A |
| 2019 | $213.45 Million | $31.34 Million | -$13.55 Million | 6.81x | N/A |
| 2020 | $362.62 Million | $29.70 Million | -$17.61 Million | 12.21x | N/A |
| 2021 | $197.79 Million | $33.64 Million | -$11.24 Million | 5.88x | N/A |
| 2022 | $50.27 Million | $27.94 Million | -$13.66 Million | 1.80x | N/A |
| 2023 | $48.62 Million | $17.32 Million | -$4.85 Million | 2.81x | N/A |
| 2024 | $50.27 Million | $19.61 Million | -$5.62 Million | 2.56x | N/A |
Competitor Companies of ICAD by Market Capitalization
Companies near icad inc in the global market cap rankings as of March 18, 2026.
Key companies related to icad inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
icad inc Historical Marketcap From 2015 to 2025
Between 2015 and today, icad inc's market cap moved from $142.02 Million to $ 106.31 Million, with a yearly change of -0.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $106.31 Million | +111.48% |
| 2024 | $50.27 Million | +3.39% |
| 2023 | $48.62 Million | -3.28% |
| 2022 | $50.27 Million | -74.58% |
| 2021 | $197.79 Million | -45.45% |
| 2020 | $362.62 Million | +69.88% |
| 2019 | $213.45 Million | +110.00% |
| 2018 | $101.64 Million | +7.56% |
| 2017 | $94.50 Million | +6.34% |
| 2016 | $88.87 Million | -37.43% |
| 2015 | $142.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of icad inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $106.31 Million USD |
| MoneyControl | $106.31 Million USD |
| MarketWatch | $106.31 Million USD |
| marketcap.company | $106.31 Million USD |
| Reuters | $106.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.